Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nuvation Bio Inc. | 748,130 | reported | 27 Feb 2026 | tx 9+3,861,875 |
| RIGEL PHARMACEUTICALS INC | 62,500 | reported | 20 Mar 2019 | tx 3+325,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | GRANT_AWARD | Nuvation Bio Inc. | 748,130 | 0.00 USD | deriv |
| 18 Jun 2025 | PURCHASE | Nuvation Bio Inc. | 10,000 | 1.71 USD | |
| 28 Feb 2025 | GRANT_AWARD | Nuvation Bio Inc. | 500,000 | 0.00 USD | deriv |
| 29 Feb 2024 | GRANT_AWARD | Nuvation Bio Inc. | 500,000 | 0.00 USD | deriv |
| 28 Feb 2023 | GRANT_AWARD | Nuvation Bio Inc. | 500,000 | 0.00 USD | deriv |
| 29 Aug 2022 | GRANT_AWARD | Nuvation Bio Inc. | 450,000 | 0.00 USD | deriv |
| 28 Feb 2022 | GRANT_AWARD | Nuvation Bio Inc. | 500,000 | 0.00 USD | deriv |
| 10 Feb 2021 | GRANT_AWARD | Nuvation Bio Inc. | 254,810 | — | deriv |
| 10 Feb 2021 | GRANT_AWARD | Nuvation Bio Inc. | 398,935 | — | deriv |
| 20 Mar 2019 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 62,500 | 0.00 USD | deriv |
| 23 Jan 2019 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 137,500 | 0.00 USD | deriv |
| 21 Mar 2018 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 125,000 | 0.00 USD | deriv |